About Kiro
Kiro is a company based in Paris (France) founded in 2019 by Alexandre Guenoun and Romain Serres. Kiro has raised $14.87 million across 1 funding round from investors including Bpifrance, Kurma Partners and Sofinnova Partners. Kiro offers products and services including Kiro Platform. Kiro operates in a competitive market with competitors including Remepy, Omda, MICA, Significo and Digital Autopsy, among others.
- Headquarter Paris, France
- Founders Alexandre Guenoun, Romain Serres
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Kiro Sas
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$14.87 M (USD)
in 1 rounds
-
Latest Funding Round
$14.87 M (USD), Series A
Mar 28, 2023
-
Investors
Bpifrance
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Kiro
Kiro offers a comprehensive portfolio of products and services, including Kiro Platform.
Secure AI tool for accessing and interpreting biology results.
People of Kiro
Unlock access to complete
Unlock access to complete
Funding Insights of Kiro
Kiro has successfully raised a total of $14.87M through 1 strategic funding round. The most recent funding activity was a Series A round of $14.87 million completed in March 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Kiro
Kiro has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Bpifrance, Kurma Partners and Sofinnova Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sofinnova Partners is focused on life sciences and healthcare investments.
|
Locked | Locked | Locked | |
|
Biotech startups are funded through venture capital in life sciences.
|
Locked | Locked | Locked | |
|
Corporate consultancy, advisory, and funding services are provided to businesses.
|
Locked | Locked | Locked |
Investor details for Kiro
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Kiro
Investment portfolio details for Kiro
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Kiro
Detailed financials for Kiro
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Kiro Comparisons
Peer comparison for Kiro
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Kiro
Kiro operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Remepy, Omda, MICA, Significo and Digital Autopsy, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Healthcare software applications are developed and provided for medical use.
|
|
| Locked | Locked | Locked |
Regulatory and security compliant software solutions are provided by Omda.
|
|
| Locked | Locked | Locked |
AI-based decision support systems are provided for radiologists.
|
|
| Locked | Locked | Locked |
Software development services are provided by Significo in Austin.
|
|
| Locked | Locked | Locked |
Advanced medical visualization is utilized for digital autopsy solutions.
|
Detailed competitors of Kiro
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Kiro
Complete news archive for Kiro
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kiro
Kiro was founded in 2019 and raised its 1st funding round 4 years after it was founded.
Kiro is headquartered in Paris, France.
Alexandre Guenoun is the current CEO of Kiro. They have also founded this company.
Kiro is a funded company, having raised a total of $14.87M across 1 funding round to date.
Kiro was founded in 2019 in Paris, France, as a provider of artificial intelligence development services targeted at the healthcare sector. Operations center on creating AI solutions for medical applications, including diagnostics and patient management tools. The company is co-led by Alexandre Guenoun as CEO and Romain Serres as CTO. Services are delivered through customized development processes to meet healthcare-specific requirements, with a focus on European markets.
Kiro's top competitors include Digital Autopsy, Ataraxis and MICA.
Kiro offers Kiro Platform.
Kiro has 3 investors. Key investors include Bpifrance, Kurma Partners, and Sofinnova Partners.